Evonik Cuts Dividend Amid Restructuring and Market Pressures

Evonik reduces dividend to €1.00 per share after 2025 earnings, citing low return on capital and falling sales. New cost-saving plan includes cutting up to 2,000 jobs.

The specialty chemicals group Evonik has met its profit targets for the past year, yet shareholders are facing a significant reduction in their dividend payouts. Management is implementing a new distribution policy and a stringent cost-saving initiative in response to declining sales and a persistently low return on capital.

Dividend Reduction Follows Solid Earnings

While Evonik's headline earnings figure appears robust, underlying challenges are prompting a strategic shift. For 2025, the company's adjusted EBITDA landed precisely at its target of €1.87 billion. However, revenue contracted by seven percent to €14.1 billion. A key structural concern remains the group's return on capital, which stood at just 6.1 percent—far below its medium-term goal of eleven percent. Consequently, the company is breaking from its previous commitment to consistent shareholder returns. The board now proposes a reduced dividend of €1.00 per share for 2025, down from the €1.17 paid out the previous year.

Strategic Response: Job Cuts and Price Adjustments

To counter margin pressure in a challenging industry environment, Evonik is deploying a multi-pronged strategy. Its "Evonik Tailor Made" transformation program includes a global workforce reduction of up to 2,000 positions, with approximately 1,500 of those cuts occurring in Germany. Upon completion this year, the move is expected to yield annual savings of €400 million. Simultaneously, the company's Advanced Technologies segment is enacting an immediate ten percent net price increase for its key animal feed product, MetAMINO. The market's cautious view of these headwinds is evident in Evonik's stock performance, with shares declining by a notable 32 percent over a twelve-month period.

Outlook for 2026 Remains Cautious

Looking ahead, Evonik anticipates continued challenges in the current fiscal year, driven by elevated energy costs and global overcapacity. Management has already revised its expected revenue corridor downward to a range of €13.5 billion to €14.5 billion. Investors can expect further operational insights from the following key dates:

• May 8, 2026: First-quarter results (Q1 2026)
• June 3, 2026: Annual General Meeting and formal dividend vote

The upcoming shareholder meeting, where approval for the reduced dividend is sought, will represent the next definitive step in the company's ongoing strategic realignment.